Paolo Cimaglia Selected Research

Paolo Cimaglia Research Topics

4	Chronic Limb-Threatening Ischemia 01/2022 - 01/2019
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 06/2014
3	Hemorrhage 10/2019 - 06/2014
2	Peripheral Arterial Disease 01/2022 - 06/2014
2	Chronic Obstructive Pulmonary Disease (COPD) 12/2021 - 01/2017
2	Heart Failure 09/2021 - 06/2014
2	Acute Kidney Injury (Acute Renal Failure) 05/2021 - 01/2021
2	Atrial Fibrillation 07/2015 - 06/2014
2	Heart Valve Diseases (Valvular Heart Disease) 07/2015 - 06/2014
1	Hypersensitivity (Allergy) 01/2022
1	Infections 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Wound Infection (Wound Infections) 02/2021
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 02/2021
1	Acute Coronary Syndrome 01/2021
1	COVID-19 12/2020
1	Inflammation (Inflammations) 11/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2020
1	Pathologic Constriction (Stenosis) 07/2020
1	Congenital Abnormalities (Deformity) 07/2020
1	Frailty 10/2019
1	Hypercholesterolemia 01/2019
1	Pain (Aches) 01/2019
1	Diabetic Foot 01/2019
1	Hypertension (High Blood Pressure) 06/2014
1	Vascular Diseases (Vascular Disease) 06/2014
1	Stroke (Strokes) 06/2014
1	Chronic Renal Insufficiency 06/2014
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2014
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2014

2	Biological ProductsIBA 01/2022 - 01/2017
2	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 10/2019 - 01/2017
2	AnticoagulantsIBA 07/2015 - 06/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	LipidsIBA 12/2021
1	TroponinIBA 01/2021
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2020
1	Lipoproteins (Lipoprotein)IBA 07/2020
1	red yeast riceIBA 01/2019
1	CholesterolIBA 01/2019
1	AntioxidantsIBA 01/2019
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2017
1	TicagrelorIBA 01/2017
1	Clopidogrel (Plavix)FDA Link 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Pharmaceutical PreparationsIBA 01/2017
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 06/2014

8	Therapeutics 01/2022 - 01/2014
4	Percutaneous Coronary Intervention 05/2021 - 01/2017
2	Limb Salvage 06/2021 - 01/2019
2	Prostheses and Implants (Prosthesis) 07/2020 - 07/2015
1	Secondary Prevention 01/2022
1	Antibiotic Prophylaxis 01/2022
1	Blood Transfusion (Blood Transfusions) 02/2021
1	Sternotomy 02/2021
1	Artificial Respiration (Mechanical Ventilation) 12/2020
1	Transcatheter Aortic Valve Replacement 07/2020
1	Conservative Treatment 01/2019